Michael Wang

3.8k citations
93 papers · 2.8k · 3 hit papers · h-index 28

Impact in

  • Hematology top 0.5%
    • Hemophilia Treatment and Research
    • Blood Coagulation and Thrombosis Mechanisms
    • Platelet Disorders and Treatments
    • Venous Thromboembolism Diagnosis and Management

Papers in

    • Hemophilia Treatment and Research 50
    • Platelet Disorders and Treatments 14
    • Blood Coagulation and Thrombosis Mechanisms 9
    • Chronic Myeloid Leukemia Treatments 4
    • Blood groups and transfusion 3
    • Coagulation, Bradykinin, Polyphosphates, and Angioedema 3

Michael Wang

90 papers receiving 2.7k citations

Michael Wang's Hit Papers

Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A 2023 · 163 citations
1630+2+4Years since publication100200300

Peers

Michael Wang
Comparison fields: 5 of 134
  • Hematology 1.6k
  • Internal Medicine 203
  • Genetics 282
  • Emergency Medical Services 89
  • Critical Care and Intensive Care Medicine 59
Replace Nathan T. Connell with:
Nathan T. Connell United States
Anupama Rao United States
R. Zimmermann Germany
Michael Krämer Germany
Daniel P. Hart United Kingdom
Μαρίνα Καρακάντζα Greece
Kyoo‐Hyung Lee South Korea
Hiroshi Imai Japan
Niels Jørgen Seersholm Denmark
Toyomi Satoh Japan
Michael Wang relative to Nathan T. Connell United States Nathan T. Connell's profile →
Citations per field
00.5×2×4×6×8×9.9×
Nathan T. Connell · 1×
Citations per year

Countries citing papers authored by Michael Wang

Since Specialization
Citations

This map shows the geographic impact of Michael Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wang more than expected).

Fields of papers citing papers by Michael Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wang. The network helps show where Michael Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Wang Line = papers co-authored together Michael Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors
Hit paper breakdown →
2019308
2
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B
Hit paper breakdown →
2023260
3 2013199
4
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A
Hit paper breakdown →
2023163
5 2003122
6 2013112
7 2017105
8 201189
9 202185
10 201161
11 202258
12 200953
13 201550
14 201349
15 201848
16 201946
17 201746
18 202042
19 201042
20 201738

About Michael Wang

Michael Wang is a scholar working on Hematology, Genetics, Internal Medicine, Surgery and Emergency Medical Services, having authored 93 papers that have together received 2.8k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (50 papers), Platelet Disorders and Treatments (14 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers), Cancer-related gene regulation (5 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Blood groups and transfusion (3 papers). The work is most often cited by research in Hematology (1.6k citations), Internal Medicine (203 citations), Genetics (282 citations), Emergency Medical Services (89 citations) and Critical Care and Intensive Care Medicine (59 citations). Michael Wang has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Marilyn J. Manco‐Johnson, David L. Cooper, Tyler W. Buckner, Neil A. Goldenberg, Brian R. Branchford, Doris V.K. Quon, Christine L. Kempton, Allen E. Waziri, Michael H. Handler and Diane K. Birks. Their work appears in journals such as Haemophilia, Blood, Pediatric Blood & Cancer, European Journal Of Haematology and Patient Preference and Adherence.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact